Lista de obras - Luca Mazzarella - Dominio Público Uruguay

A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data

artículo científico publicado en 2017

A new approach to assess drug sensitivity in cells for novel drug discovery.

artículo científico publicado en 2018

Are we ready for routine precision medicine? Highlights from the Milan Summit on Precision Medicine, Milan, Italy, 8-9 February 2018.

artículo científico publicado en 2018

Cetuximab for treating non-small cell lung cancer.

artículo científico publicado en 2018

Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer.

artículo científico publicado en 2018

Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis

artículo científico publicado en 2019

Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in Pt(II) complexes on human carcinoma cell lines: a comparative study with cisplatin.

artículo científico publicado en 2013

DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes.

artículo científico publicado en 2014

Embryonic stem cell-derived hemangioblasts remain epigenetically plastic and require PRC1 to prevent neural gene expression.

artículo científico publicado en 2010

Entinostat for the treatment of breast cancer.

artículo científico

Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage.

artículo científico publicado en 2010

Genetic alterations in hepatoblastoma and hepatocellular carcinoma associated with familial adenomatous polyposis

artículo científico publicado en 2003

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma.

scientific article published on 21 June 2010

Highlights from the 58th meeting of the American Society of Haematology, 1-6 December 2016, San Diego, USA.

artículo científico publicado en 2017

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

artículo científico publicado en 2011

Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators.

artículo científico publicado en 2010

Liver toxicity in the era of immune checkpoint inhibitors: A practical approach

scientific article published on 03 October 2018

Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in mice.

artículo científico publicado en 2016

Master protocols in immuno-oncology: do novel drugs deserve novel designs?

scientific article published on 01 March 2020

Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.

artículo científico publicado en 2013

Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism

artículo científico publicado en 2019

Orlando Magic: report from the 57th meeting of the American Society of Haematology, 5-7 December 2015, Orlando, USA.

artículo científico publicado en 2016

Rise of the mutants: report from the 19th conference of the European Haematology Association, Milan, 12-15 June 2014

artículo científico publicado en 2014

Runx proteins regulate Foxp3 expression

artículo científico publicado en 2009

Semantic and geographical analysis of Covid-19 trials reveals a fragmented clinical research landscape likely to impair informativeness.

artículo científico publicado en 2020

Tales from the Jazz ASH: highlights from the 2013 American Society of Haematology meeting.

artículo científico publicado en 2014

The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review

artículo científico publicado en 2019

The genomic and epigenomic landscapes of AML.

artículo científico publicado en 2014

Tumor mutational burden quantification from targeted gene panels: major advancements and challenges

scientific article published on 15 July 2019

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

artículo científico publicado en 2017

Why does obesity promote cancer? Epidemiology, biology, and open questions

artículo científico publicado en 2015

p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value

artículo científico publicado en 2019

Lista de obras de Luca Mazzarella

A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data

A new approach to assess drug sensitivity in cells for novel drug discovery.

Are we ready for routine precision medicine? Highlights from the Milan Summit on Precision Medicine, Milan, Italy, 8-9 February 2018.

Cetuximab for treating non-small cell lung cancer.

Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer.

Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis

Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in Pt(II) complexes on human carcinoma cell lines: a comparative study with cisplatin.

DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes.

Embryonic stem cell-derived hemangioblasts remain epigenetically plastic and require PRC1 to prevent neural gene expression.

Entinostat for the treatment of breast cancer.

Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage.

Genetic alterations in hepatoblastoma and hepatocellular carcinoma associated with familial adenomatous polyposis

High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma.

Highlights from the 58th meeting of the American Society of Haematology, 1-6 December 2016, San Diego, USA.

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators.

Liver toxicity in the era of immune checkpoint inhibitors: A practical approach

Maintenance of leukemic cell identity by the activity of the Polycomb complex PRC1 in mice.

Master protocols in immuno-oncology: do novel drugs deserve novel designs?

Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.

Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies studies and correlation with flt3 mutations and polyunsaturated fatty acid metabolism

Orlando Magic: report from the 57th meeting of the American Society of Haematology, 5-7 December 2015, Orlando, USA.

Rise of the mutants: report from the 19th conference of the European Haematology Association, Milan, 12-15 June 2014

Runx proteins regulate Foxp3 expression

Semantic and geographical analysis of Covid-19 trials reveals a fragmented clinical research landscape likely to impair informativeness.

Tales from the Jazz ASH: highlights from the 2013 American Society of Haematology meeting.

The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review

The genomic and epigenomic landscapes of AML.

Tumor mutational burden quantification from targeted gene panels: major advancements and challenges

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

Why does obesity promote cancer? Epidemiology, biology, and open questions

p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value